Cited by 109Ovarian function and disordersMetabolism, Diabetes, and CancerAdrenal Hormones and Disorders

Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain

Hirsch, Andrea, Hahn, Dagmar, Kempná, Petra, Hofer, Gaby, Nuoffer, Jean-Marc, Mullis, Primus E., Flück, Christa E.·2012·Endocrinology

Abstract

Metformin is treatment of choice for the metabolic consequences seen in polycystic ovary syndrome for its insulin-sensitizing and androgen-lowering properties. Yet, the mechanism of action remains unclear. Two potential targets for metformin regulating steroid and glucose metabolism are AMP-activated protein kinase (AMPK) signaling and the complex I of the mitochondrial respiratory chain. Androgen biosynthesis requires steroid enzymes 17α-Hydroxylase/17,20 lyase (CYP17A1) and 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2), which are overexpressed in ovarian cells of polycystic ovary syndrome women. Therefore, we aimed to understand how metformin modulates androgen production using NCI-H295R cells as an established model of steroidogenesis. Similar to in vivo situation, metformin inhibited androgen production in NCI cells by decreasing HSD3B2 expression and CYP17A1 and HSD3B2 activities. The effect of metformin on androgen production was dose dependent and subject to the presence of organic cation transporters, establishing an important role of organic cation transporters for metformin's action. Metformin did not affect AMPK, ERK1/2, or atypical protein kinase C signaling. By contrast, metformin inhibited complex I of the respiratory chain in mitochondria. Similar to metformin, direct inhibition of complex I by rotenone also inhibited HSD3B2 activity. In conclusion, metformin inhibits androgen production by mechanisms targeting HSD3B2 and CYP17-lyase. This regulation involves inhibition of mitochondrial complex I but appears to be independent of AMPK signaling.

Integrity signals

Registry

Crossref · 10.1210/en.2012-1145

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The antiandrogenic effects of resveratrol in PCOS women are probably indirect and driven by the reduction of insulin resistance, in contrast to pharmacologic intervention with metformin.

    “Given that chronic hyperinsulinemia can stimulate an excessive production of androgens in PCOS women, the antiandrogenic effects of resveratrol are probably indirect and driven by the reduction of IR in these patients [141,142,143,144], in contrast to pharmacologic intervention with metformin [145,146].”

Cites

1 retracted

Flagged first, then by citations

2 of the 68 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Hirsch, A., Hahn, D., Kempná, P., Hofer, G., Nuoffer, J.-M., Mullis, P. E., & Flück, C. E.
Affiliations
  • University Children’s Hospital Bern (CH)
  • University of Bern (CH)
Corresponding author
Flück, Christa E.
Venue
Endocrinology
Published
2012-09-01
Volume
153
Issue
9
Pages
4354-4366
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2134583596
Cited by
109
References
68
Citations by year
2026: 4 · 2025: 12 · 2024: 13 · 2023: 12 · 2022: 17 · 2021: 7 · 2020: 14 · 2019: 3 · 2018: 2 · 2017: 8 · 2016: 3 · 2015: 2 · 2014: 7 · 2013: 4 · 2012: 1
FWCI
5.22
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
metformin, androgen production, polycystic ovary syndrome, HSD3B2, CYP17A1, steroidogenic enzymes, mitochondrial complex I, electron transport chain, organic cation transporters, AMPK, H295R cells, rotenone, insulin-sensitizing drugs
MeSH terms
Androgens, Cell Line, Humans, Metformin, Progesterone Reductase, Steroid 17-alpha-Hydroxylase, Reverse Transcriptase Polymerase Chain Reaction, Organic Cation Transport Proteins, Electron Transport Complex I, Cell Proliferation, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review